118 related articles for article (PubMed ID: 23881928)
1. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
Gopalakrishnan R; Matta H; Chaudhary PM
Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
[TBL] [Abstract][Full Text] [Related]
2. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
4. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation.
Dabaghmanesh N; Matsubara A; Miyake A; Nakano K; Ishida T; Katano H; Horie R; Umezawa K; Watanabe T
Cancer Sci; 2009 Apr; 100(4):737-46. PubMed ID: 19469019
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
Sun Q; Matta H; Chaudhary PM
Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
[TBL] [Abstract][Full Text] [Related]
7. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
8. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
[TBL] [Abstract][Full Text] [Related]
9. Probing the Solution Structure of IκB Kinase (IKK) Subunit γ and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit β by EPR Spectroscopy.
Bagnéris C; Rogala KB; Baratchian M; Zamfir V; Kunze MB; Dagless S; Pirker KF; Collins MK; Hall BA; Barrett TE; Kay CW
J Biol Chem; 2015 Jul; 290(27):16539-49. PubMed ID: 25979343
[TBL] [Abstract][Full Text] [Related]
10. Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma.
Dai L; Trillo-Tinoco J; Cao Y; Bonstaff K; Doyle L; Del Valle L; Whitby D; Parsons C; Reiss K; Zabaleta J; Qin Z
Blood; 2015 Dec; 126(26):2821-31. PubMed ID: 26531163
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
Ishikawa C; Mori N
Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
[TBL] [Abstract][Full Text] [Related]
12. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
[TBL] [Abstract][Full Text] [Related]
13. BIIB021, an orally available and small-molecule inhibitor of HSP90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa).
Güven CM; Özgür A
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7299-7308. PubMed ID: 37606138
[TBL] [Abstract][Full Text] [Related]
14. Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.
Wu Y; Wang V; Yarchoan R
Sci Rep; 2024 Feb; 14(1):4125. PubMed ID: 38374336
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor BIIB021 in human bladder cancer cell line.
Asdemir A; Özgür A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5167-5177. PubMed ID: 38240781
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.
White MC; Wong JP; Damania B
Cancer Res Commun; 2024 Apr; 4(4):1024-1040. PubMed ID: 38592451
[TBL] [Abstract][Full Text] [Related]
17. CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death.
Kuehnle N; Osborne SM; Liang Z; Manzano M; Gottwein E
Cell Death Differ; 2023 May; 30(5):1221-1234. PubMed ID: 36801923
[TBL] [Abstract][Full Text] [Related]
18. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
Wong JP; Stuhlmiller TJ; Giffin LC; Lin C; Bigi R; Zhao J; Zhang W; Bravo Cruz AG; Park SI; Earp HS; Dittmer DP; Frye SV; Wang X; Johnson GL; Damania B
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16541-16550. PubMed ID: 31346082
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
Sin SH; Roy D; Wang L; Staudt MR; Fakhari FD; Patel DD; Henry D; Harrington WJ; Damania BA; Dittmer DP
Blood; 2007 Mar; 109(5):2165-73. PubMed ID: 17082322
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma.
Moodad S; El Hajj R; Hleihel R; Hajjar L; Tawil N; Karam M; Hamie M; Abou Merhi R; El Sabban M; El Hajj H
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32883022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
